364 related articles for article (PubMed ID: 25900170)
1. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
Wong D; Wong T; Romney M; Leung V
BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
McDanel JS; Roghmann MC; Perencevich EN; Ohl ME; Goto M; Livorsi DJ; Jones M; Albertson JP; Nair R; O'Shea AMJ; Schweizer ML
Clin Infect Dis; 2017 Jul; 65(1):100-106. PubMed ID: 28379314
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
Wong D; Wong T; Romney M; Leung V
Ann Clin Microbiol Antimicrob; 2016 Apr; 15():27. PubMed ID: 27112143
[TBL] [Abstract][Full Text] [Related]
5. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
6. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
Li J; Echevarria KL; Traugott KA
Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
La YJ; Kim HR; Oh DH; Ahn JY; Kim YC
Yonsei Med J; 2022 Jul; 63(7):611-618. PubMed ID: 35748072
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
Blumenthal KG; Shenoy ES; Huang M; Kuhlen JL; Ware WA; Parker RA; Walensky RP
PLoS One; 2016; 11(7):e0159406. PubMed ID: 27438379
[TBL] [Abstract][Full Text] [Related]
9. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
Trials; 2016 Mar; 17():170. PubMed ID: 27029920
[TBL] [Abstract][Full Text] [Related]
10. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
11. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK; Marco F; Wray D; Kanafani ZA; Carugati M; Durante-Mangoni E; Tattevin P; Chu VH; Moreno A; Fowler VG; Miró JM;
Clin Microbiol Infect; 2017 Aug; 23(8):544-549. PubMed ID: 28159672
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Dilworth TJ; Casapao AM; Ibrahim OM; Jacobs DM; Bowers DR; Beyda ND; Mercier RC
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617094
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
Seas C; Garcia C; Salles MJ; Labarca J; Luna C; Alvarez-Moreno C; Mejía-Villatoro C; Zurita J; Guzmán-Blanco M; Rodríguez-Noriega E; Reyes J; Arias CA; Carcamo C; Gotuzzo E;
J Antimicrob Chemother; 2018 Jan; 73(1):212-222. PubMed ID: 29045648
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible
Fletcher JM; Kram SJ; Sarubbi CB; Anderson DJ; Kram BL
J Pharm Pract; 2019 Aug; 32(4):375-381. PubMed ID: 29310494
[TBL] [Abstract][Full Text] [Related]
16. Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.
Canty E; Carnahan B; Curley T; Anususinha E; Hamdy RF; Ericson JE
Pediatr Infect Dis J; 2021 May; 40(5):429-433. PubMed ID: 33196562
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
Yetmar ZA; Khodadadi RB; Go JR; Chesdachai S; Abu Saleh OM
Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):423-430. PubMed ID: 36800065
[TBL] [Abstract][Full Text] [Related]
18. Penicillin versus anti-staphylococcal beta-lactams for penicillin-susceptible Staphylococcus aureus blood stream infections: a retrospective cohort study.
Reynolds G; Crawford S; Cuenca J; Ghosh N; Newton P
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):147-151. PubMed ID: 34432165
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Evaluation of the Association of Oxacillin MIC on Acute Treatment Outcomes with Cefazolin and Antistaphylococcal Penicillins in Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Hess KA; Kooda K; Shulha JA; Mara K; Go JR; Fida M; DeSimone DC; Stevens RW
J Clin Microbiol; 2023 Apr; 61(4):e0003923. PubMed ID: 36988505
[TBL] [Abstract][Full Text] [Related]
20. The Daniel K. Inouye College of Pharmacy Scripts: The Effects of Vancomycin Use and De-escalation in Patients Hospitalized with Pneumonia.
You AS; Fukunaga BT; Hanlon AL; Lozano AJ; Goo RA
Hawaii J Med Public Health; 2018 Oct; 77(10):261-267. PubMed ID: 30324005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
